Lantheus (LNTH)
(Delayed Data from NSDQ)
$112.50 USD
+0.54 (0.48%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $112.50 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$112.50 USD
+0.54 (0.48%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $112.50 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Has Cardiff Oncology (CRDF) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Cardiff Oncology (CRDF) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year.
Put These 5 Relative Price Strength Stocks on Your Radar
by Nilanjan Choudhury
LNTH, MCHP, TMHC, VIPS and MYRG are five stocks with explosive relative price strength.
Top Stock Picks for Week of March 13, 2023
by Panel Of Zacks Experts
A Cutting-Edge Medical Products Growth Stock and an Impressive Value Stock.
Zacks.com featured highlights include Encore Wire, ICF International, Lantheus Holdings and Tecnoglass
by Zacks Equity Research
Encore Wire, ICF International, Lantheus Holdings and Tecnoglass are part of the Zacks Screen of the Week article.
Here is Why Growth Investors Should Buy Lantheus Holdings (LNTH) Now
by Zacks Equity Research
Lantheus Holdings (LNTH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
4 Stocks With Solid Net Profit Margin to Boost Portfolio Return
by Anirudha Bhagat
Let's take a look at four top-ranked stocks - WIRE, ICFI, LNTH and TGLS - with impressive net profit margins for a winning portfolio.
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Here's Why You Should Add Stryker (SYK) Stock to Your Portfolio
by Zacks Equity Research
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.
Zacks.com featured highlights UWM Holdings, Perion Network, Lantheus Holdings and Goosehead Insurance
by Zacks Equity Research
UWM Holdings, Perion Network, Lantheus Holdings and Goosehead Insurance have been highlighted in this Screen of The Week article.
Humana (HUM) Ties Up To Offer Value-Based Care to MA Members
by Zacks Equity Research
Humana (HUM) inks a 10-year collaboration with Aledade to ensure continued value-based primary care to its Medicare Advantage members from Aledade-backed physicians.
Add These 4 Top-Ranked Liquid Stocks For Healthy Gains
by Vaishali Doshi
Here are four top-ranked liquid stocks, Goosehead Insurance (GSHD), Lantheus Holdings (LNTH), Perion (PERI) and UWM Holdings (UWMC), which investors can add to their portfolio for strong gains.
Lantheus and NuVasive have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Lantheus and NuVasive have been highlighted as Zacks Bull and Bear of the Day.
Bull of the Day: Lantheus (LNTH)
by Kevin Cook
Stunning "beat-and-raise" quarter has analysts scrambling to raise estimates and price targets above $110
2 Medical Stocks to Buy Right Now
by Shaun Pruitt
There is always an essential need for healthcare and here are two Zacks Rank #1 (Strong Buy) medical stocks that investors should consider buying right now.
Best Momentum Stock to Buy for March 1st
by Zacks Equity Research
LNTH, CM and BIDU made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 1, 2023.
Wall Street Analysts Predict a 41.16% Upside in Lantheus Holdings (LNTH): Here's What You Should Know
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 41.2% in Lantheus Holdings (LNTH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Is Albireo Pharma (ALBO) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Albireo Pharma (ALBO) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year.
Lantheus Holdings (LNTH) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 42.71% and 7.59%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Lantheus Holdings (LNTH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Lantheus Holdings (LNTH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Veru Inc. (VERU) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Veru Inc. (VERU) delivered earnings and revenue surprises of -21.05% and 50.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Exact Sciences (EXAS) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Continued increase in Cologuard volume is likely to have benefited Exact Sciences (EXAS) Q4 performance.
Zacks.com featured highlights Arch Resources, International Game Technology, Old Second Bancorp and Lantheus
by Zacks Equity Research
Arch Resources, International Game Technology, Old Second Bancorp and Lantheus have been highlighted in this Screen of The Week article.
4 Stocks With Solid Net Profit Margin to Boost Portfolio Return
by Anirudha Bhagat
Let's take a look at four top-ranked stocks - Arch Resources (ARCH), International Game Technology (IGT), Old Second Bancorp (OSBC) and Lantheus Holdings (LNTH) - with solid net profit margins.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.